News

Fierce Pharma1h

Novo plant acquired in Catalent buyout faces renewed FDA scrutiny with Form 483: STAT

Despite boasting a new owner, the Indiana manufacturing plant Novo Nordisk picked up as part of its parent company's Catalent ...
BioSpace4h

Novo-Acquired Catalent Plant Plagued by Unresolved Pest, Contamination Issues, FDA Finds

The FDA has identified critical lapses at a production facility operated by Novo Nordisk that is used by several drugmakers, ...

Ozempic Maker Novo Nordisk Freezes Hiring Amid Ongoing Struggles

No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish ...
24/7 Wall St.35m

Novo Nordisk Roars Back: 6 Catalysts Driving the Pharma's Path to Dominance

A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...

Novo Nordisk slashes price of Ozempic to $499 for cash-paying, uninsured patients

Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.
NJBIZ2d

Novo Nordisk halves Ozempic price to $499 for US patients

Novo Nordisk lowers Ozempic cost to $499 per month for uninsured U.S. patients, expanding access through NovoCare and 70,000 ...
24/7 Wall St.1d

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (Aug 2025)

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...